These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 14678864)

  • 1. Obesity as a cardiovascular risk factor.
    Sowers JR
    Am J Med; 2003 Dec; 115 Suppl 8A():37S-41S. PubMed ID: 14678864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance: the link between obesity and cardiovascular disease.
    Reaven GM
    Med Clin North Am; 2011 Sep; 95(5):875-92. PubMed ID: 21855697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease and modifiable cardiometabolic risk factors.
    Cannon CP
    Clin Cornerstone; 2008; 9(2):24-38; discussion 39-41. PubMed ID: 19410160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease and modifiable cardiometabolic risk factors.
    Cannon CP
    Clin Cornerstone; 2007; 8(3):11-28. PubMed ID: 18452839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, insulin resistance, and cardiovascular disease.
    Reaven G; Abbasi F; McLaughlin T
    Recent Prog Horm Res; 2004; 59():207-23. PubMed ID: 14749503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overweight, hypertension and cardiovascular disease: focus on adipocytokines, insulin, weight changes and natriuretic peptides.
    Seven E
    Dan Med J; 2015 Nov; 62(11):B5163. PubMed ID: 26522487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
    Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
    Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analyses among overweight, insulin resistance, and cardiovascular risk factors in children.
    Reinehr T; de Sousa G; Andler W
    Obes Res; 2005 Oct; 13(10):1824-33. PubMed ID: 16286531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiometabolic risk markers of normal weight and excess body weight in Brazilian adolescents.
    Mastroeni SS; Mastroeni MF; Gonçalves Mde C; Debortoli G; da Silva NN; Bernal RT; Adamovski M; Veugelers PJ; Rondó PH
    Appl Physiol Nutr Metab; 2016 Jun; 41(6):659-65. PubMed ID: 27227571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From obesity to diabetes.
    Keller U
    Int J Vitam Nutr Res; 2006 Jul; 76(4):172-7. PubMed ID: 17243079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.
    Seven E; Husemoen LL; Sehested TS; Ibsen H; Wachtell K; Linneberg A; Jeppesen JL
    PLoS One; 2015; 10(6):e0128987. PubMed ID: 26035431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
    Appel SJ; Harrell JS; Davenport ML
    J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter.
    Goralski KB; Sinal CJ
    Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, abdominal obesity, and insulin resistance.
    Westphal SA
    Clin Cornerstone; 2008; 9(1):23-29; discussion 30-1. PubMed ID: 19046737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overweight and obesity: the pathogenesis of cardiometabolic risk.
    Bray GA; Clearfield MB; Fintel DJ; Nelinson DS
    Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.